Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD

NCT04606394 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Trelegy Ellipta 100/62.5/25Mcg Inh 30D
DRUG: Ventolin 90Mcg/Actuation Inhalation Aerosol

Sponsor

Pulmonary Research Institute of Southeast Michigan

Collaborators

[object Object]